Dr. Junker has spent over 25 years developing and commercializing therapeutic products for biotechnology and drug companies. He has served as an advisor to Cetya since March 2013, its VP of Operations and Preclinical Development since July 2014, and Chief Scientific Office since July 2020. Dr. Junker was previously a consultant to Amgen, Ampio Pharmaceuticals, Novartis, and other companies supporting the development of products from preclinical to marketed stages. He worked to commercialize bone growth factor products for 8 years as founder and COO of Coragen Biologics from 2001 to 2004 and as Director of Process Development and Engineering at Sulzer Biologics from 1996 to 2001. Dr. Junker held positions of increasing responsibility in Process Development Groups at Synergen and Somatogen and was a Postdoctoral Fellow and junior Faculty member at the University of Colorado Health Sciences Center from 1986 to 1989. Dr. Junker holds a Ph.D. from the Department of Nutritional Sciences, Purdue University and a B.S. in Biology and Chemistry from Western Michigan University.
Louis H. Junker, Ph.D.
Chief Scientific Officer